Sorrento Presents Preliminary Results of STI-2020 Against COVID-19
PharmaShots Weekly Snapshot (March 02-06, 2020)
Published: Mar 06, 2020 | Tags: Mount Sinai, Signs, Multi-Year, Collaboration, Harbour BioMed, Develop, Novel Biotherapies, Multiple Cancer Indications, COVID-19
Published: Mar 06, 2020 | Tags: AstraZeneca, Reports, Results, Imfinzi, Tremelimumab, P-III, DANUBE, Study, Unresectable, Stage IV, Bladder Cancer
Published: Mar 05, 2020 | Tags: Allergan, Durysta, bimatoprost implant, Receives, US, FDA, Approval, First, Intracameral, Biodegradable, Sustained-Release Implant, Patients, OAG, OHT
Published: Mar 05, 2020 | Tags: Zydus, Saroglitazar, Receives, DCGI, Approval, World, First Therapy, Non-Cirrhotic, NASH, India
Published: Mar 05, 2020 | Tags: Novartis, Enters, Four-Year, Collaboration, Orionis Biosciences, Tackle, Intractable, Disease Targets
6. The US FDA Informs About Cybersecurity Vulnerabilities in Medical Devices with Bluetooth Low Energy
Published: Mar 04, 2020 | Tags: US, FDA, Informs, About, Cybersecurity Vulnerabilities, Medical Devices, Bluetooth Low Energy
Published: Mar 05, 2020 | Tags: Heat Biologics, Signs, Research Collaboration, University of Miami, Develop, Vaccine, Against, COVID-19
8. Zuellig Pharma Acquires Alliance Pharma (Cambodge) to Bolster its Presence in Indochina
Published: Mar 05, 2020 | Tags: Zuellig Pharma, Acquires, Alliance Pharma, Cambodge, Bolster, Presence, Indochina
9. Roche’s Actemra (tocilizumab) Receives Approval to Combat Coronavirus Complications in China
Published: Mar 04, 2020 | Tags: Roche, Actemra, tocilizumab, Receives, Approval, Combat, Coronavirus Complications, China
Published: Mar 04, 2020 | Tags: Alopexx, Signs, Exclusive, License Agreement, Beijing Shenogen Pharma, Develop, Commercialize, DI-LEU16-IL2, B-Cell Lymphomas, China, Asia
Published: Mar 04, 2020 | Tags: Allergan, Editas, Report, First Patient Dosing, P-I/II, BRILLIANCE Study, AGN-151587, EDIT-101, Treat, LCA10
12. Vir and Alnylam Expand their 2017 License Agreement to Target COVID-19
Published: Mar 04, 2020 | Tags: Vir, Alnylam, Expand, 2017, License Agreement, Target, COVID-19
Published: Mar 04, 2020 | Tags: Janssen, Reports, Submission, MAA, EMA, Ponesimod, Treat, Patients, Relapsing Multiple Sclerosis
14. Iktos and SRI Collaborate to Accelerate Discovery and Development of Novel Anti-Viral Therapies
Published: Mar 03, 2020 | Tags: Iktos, SRI, Collaborate, Accelerate, Discovery, Development, Novel, Anti-Viral Therapies
Published: Mar 03, 2020 | Tags: Alnylam, Givlaari, givosiran, Receives, EC, Approval, Acute Hepatic Porphyria, AHP, Adults, Adolescents
16. Takeda to Initiate the Development of Plasma-Derived Therapy to Treat Corona Virus (COVID-19)
Published: Mar 04, 2020 | Tags: Takeda, Initiate, Development, Plasma-Derived Therapy, Treat, Corona Virus, COVID-19
Published: Mar 03, 2020 | Tags: Roche, Elecsys GALAD scores, Receives, US, FDA, Breakthrough Device Designation, Earlier Diagnosis, Hepatocellular Carcinoma
18. BMS Collaborates with Voluntis to Co-Develop Digital Therapies to Treat Cancer Indications
Published: Mar 03, 2020 | Tags: BMS, Collaborates, Voluntis, Co-Develop, Digital Therapies, Cancer
Published: Mar 03, 2020 | Tags: Novartis, Mayzent, Receives, Health Canada, Approval, Secondary Progressive Multiple Sclerosis, Active Disease
Published: Mar 02, 2020 | Tags: Lucid Diagnostics, Collaborates, University of Pennsylvania, Evaluate, EsoCheck, Patients, Eosinophilic Esophagitis
Published: Mar 03, 2020 | Tags: Genentech, Esbriet, pirfenidone, Receives, FDA, Breakthrough Therapy Designation, Unclassifiable, Interstitial Lung Disease
22. Insulet to Halt Study of Omnipod Horizon Due to Software Anomaly
Published: Mar 03, 2020 | Tags: Insulet, Discontinue, Study, Omnipod Horizon, Software Anomaly
23. Thermo Fisher Scientific to Acquire QIAGEN for ~$11.5B
Published: Mar 03, 2020 | Tags: Thermo Fisher Scientific, Acquire, QIAGEN, ~$11.5B
Published: Mar 02, 2020 | Tags: Sanofi, Sarclisa, isatuximab-irfc, Receives, US, FDA, Approval, Relapsed Refractory Multiple Myeloma
Published: Mar 02, 2020 | Tags: uniQure, Signs, Exclusive, Research, License Agreement, Gen-X, Develop, Novel Synthetic Promoters
Published: Mar 02, 2020 | Tags: Pfizer, Eli Lilly, Report, US, FDA, Acceptance, BLA, Tanezumab, Treat, Chronic Pain, Moderate-to-Severe, Osteoarthritis
27. Gilead to Acquire Forty Seven for $4.9B
Published: Mar 02, 2020 | Tags: Gilead, Acquire, Forty Seven, $4.9B
Published: Mar 02, 2020 | Tags: Takeda, Divest, Portfolio, Select OTC, Non-Core Assets, Hypera Pharma, Latin America, $825M
29. Medexus Acquires Aptevo BioTherapeutics for its Hematology Asset IXINITY
Published: Feb 28, 2020 | Tags: Medexus, Acquires, Aptevo BioTherapeutics, Hematology Asset, IXINITY
Published: Feb 28, 2020 | Tags: Boehringer Ingelheim, Nintedanib, Receives, CHMP, Positive Opinion, Treat, Systemic Sclerosis-Associated Interstitial Lung Disease
Published: Mar 02, 2020 Tags: Merck KGaA, ERBITUX, cetuximab, Receives, NMPA, Approval, 1L, Treatment, Recurrent/ Metastatic, Squamous Cell Carcinoma of Head and Neck